ScholarIQanswers from OpenAlex & ORCID
James C. Yang
ResearcherPublications, citations & collaboration network
James C. Yang is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does James C. Yang have?
ScholarIQindexed works
James C. Yang has 327 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does James C. Yang have?
ScholarIQcitation count
James C. Yang has 33,822 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of James C. Yang?
ScholarIQh-index
James C. Yang has an h-index of 69 in OpenAlex.
What is the i10-index of James C. Yang?
ScholarIQi10-index
James C. Yang has an i10-index of 122 in OpenAlex.
What is the ORCID of James C. Yang?
ScholarIQorcid
The ORCID for James C. Yang is on the source record.
What is the OpenAlex record for James C. Yang?
ScholarIQopenalex
The OpenAlex for James C. Yang is on the source record.
What are the most-cited papers on James C. Yang?
ScholarIQmost cited works
Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
Paul F. Robbins, Richard A. Morgan, Steven A. Feldman, James C. Yang, Richard M. Sherry, Mark E. Dudley, John R. Wunderlich, Azam Nahvi, Lee J. Helman, Crystal L. Mackall, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Mark Raffeld, Chyi‐Chia Richard Lee, Catherine Lévy, Yong F. Li, Mona El‐Gamil, Susan Schwarz, Carolyn M. Laurençot, Steven A. Rosenberg
Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
James N. Kochenderfer, Mark E. Dudley, Sadik H. Kassim, Robert Somerville, Robert O. Carpenter, Maryalice Stetler‐Stevenson, James C. Yang, Giao Q. Phan, Marybeth S. Hughes, Richard M. Sherry, Mark Raffeld, Steven A. Feldman, Lily Lu, Yong F. Li, Lien T. Ngo, André Goy, Tatyana Feldman, David Spaner, Michael Wang, Clara C. Chen, Sarah M. Kranick, Avindra Nath, Debbie-Ann N. Nathan, Kathleen E. Morton, Mary Ann Toomey, Steven A. Rosenberg
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma
Stephanie L. Goff, Richard A. Morgan, James C. Yang, Richard M. Sherry, Paul F. Robbins, Nicholas P. Restifo, Steven A. Feldman, Yong‐Chen Lu, Lily Lu, Zhili Zheng, Liqiang Xi, Monica Epstein, Lori McIntyre, Parisa Malekzadeh, Mark Raffeld, Howard A. Fine, Steven A. Rosenberg
CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors
Linchun Jin, Haipeng Tao, Aida Karachi, Yu Long, Alicia Y. Hou, Na Meng, Kyle Dyson, Adam Grippin, Loic P. Deleyrolle, Wang Zhang, Didier A. Rajon, Qiong J. Wang, James C. Yang, Jesse Kresak, Elias Sayour, Maryam Rahman, Frank J. Bova, Zhiguo Lin, Duane A. Mitchell, Jianping Huang
Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study
Smita S. Chandran, Robert Somerville, James C. Yang, Richard M. Sherry, Christopher A. Klebanoff, Stephanie L. Goff, John R. Wunderlich, David N. Danforth, Daniel Zlott, Biman C. Paria, Arvind Sabesan, Abhishek K. Srivastava, Liqiang Xi, Trinh Pham, Mark Raffeld, Donald E. White, Mary Ann Toomey, Steven A. Rosenberg, Udai S. Kammula